Scientists test new Tumor-Tracking tracer in patients
Knowledge-focused
Completed
This was a first-in-human study to test a new radioactive imaging agent called 68Ga-NOTA-SNA002. It involved 17 adult patients with various solid tumors to see if the agent was safe and to measure how much radiation the body absorbs from it. The main goal was to understand how th…
Phase: PHASE1 • Sponsor: SmartNuclide Biopharma • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC